Pharmswell Bio Co Ltd (043090.KQ) Key Developments | Reuters.com
Edition:
United States

Analyst Research

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00
Provider : Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

PharmswellBio to acquire stake in Korea-based company


Tuesday, 22 Jul 2014 04:41am EDT 

PharmswellBio Co., Ltd:To acquire 24.69 pct (6,000,000 shares) in a Korea-based company (target company), which is engaged in manufacturing of medical machine, as well as import and export business.Transaction amount of 3 bln won.To hold 24.69 pct stake in target company, after the transaction. 

Company Quote

4770.0
-20.0 -0.42%
29 Jun 2016